Weight loss often brings a small drop in bone density, including with GLP-1 medications. Trials suggest regular exercise, especially resistance training, limits that loss, alongside enough calcium and vitamin D and screening when appropriate.
Losing a meaningful amount of weight usually comes with some loss of bone density, and weight loss supported by a GLP-1 medication is no exception. The encouraging part is that recent randomized trials suggest regular exercise, particularly resistance training, limits much of that loss. Pairing treatment with strength work, enough calcium and vitamin D, and screening when your age or history calls for it is the practical way to protect your skeleton while your weight changes.
Researchers writing in JAMA Network Open in 2024 summarized the problem plainly: bone loss typically accompanies weight loss, showing up as lower bone mineral density and higher bone turnover. Low bone density is associated with a higher risk of fractures. The authors noted that this is a particular concern in older adults, but that weight-related bone loss has also been seen in younger adults, which suggests it matters across the lifespan.
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) calls osteoporosis a "silent" disease because there are typically no symptoms until a bone breaks, most often at the hip, spine or wrist. NIAMS lists several factors that raise risk:
If several of these apply to you, bone health deserves extra attention during any weight-loss effort.
Two randomized trials offer the clearest picture.
The 2024 JAMA Network Open trial. Investigators in Denmark enrolled 195 adults aged 18 to 65 with obesity and without diabetes. After an 8-week low-calorie diet, participants were assigned for 52 weeks to an exercise program, the GLP-1 medication liraglutide, both combined, or placebo. Estimated average weight losses over the study were 7.03 kg with placebo, 11.19 kg with exercise, 13.74 kg with liraglutide and 16.88 kg with the combination. Despite the largest weight loss, the combination group's bone density at the hip and lumbar spine was unchanged compared with placebo. Liraglutide alone, by contrast, reduced hip and spine bone density compared with exercise alone, even though weight loss in those two groups was similar.
The 2017 NEJM trial in older adults. Researchers randomized 160 older adults with obesity to a weight-management program plus aerobic training, resistance training, or both, or to a control group. All three exercise groups lost about 9 percent of body weight. Hip bone density and lean mass held up best when resistance work was part of the plan:
| Training added to weight loss | Change in total hip bone density | Change in lean mass |
|---|---|---|
| Aerobic only | 3% decrease | 5% decrease |
| Resistance only | 0.5% decrease | 2% decrease |
| Aerobic plus resistance | 1% decrease | 3% decrease |
The combined group also improved the most on the trial's main measure of physical function.
A few caveats are worth keeping in mind. Liraglutide is an earlier GLP-1 medication, so the 2024 results may not transfer exactly to semaglutide or tirzepatide. These are averages from controlled trials, and individual results vary. Still, the direction of both studies is consistent: exercise, and resistance training in particular, appears to be the most reliable tool you have for protecting bone while weight comes down.
The Physical Activity Guidelines for Americans recommend that adults get 150 to 300 minutes of moderate-intensity aerobic activity each week plus muscle-strengthening activity, such as lifting weights or doing push-ups, at least 2 days each week. NIAMS specifically highlights weight-bearing exercise such as walking for bone health. Our strength training starting guide walks through beginner-friendly movements. If you already have osteoporosis or a history of fractures, ask your licensed provider which exercises are appropriate before starting.
The NIH Office of Dietary Supplements (ODS) lists these recommended amounts for adults:
| Group | Recommended calcium |
|---|---|
| Adults 19 to 50 | 1,000 mg |
| Men 51 to 70 | 1,000 mg |
| Women 51 to 70 | 1,200 mg |
| Adults 71 and older | 1,200 mg |
Milk, yogurt and cheese are the main sources for most people in the US, according to ODS. Canned sardines and salmon with bones, kale, broccoli, bok choy, and calcium-fortified plant milks, tofu and cereals also contribute. ODS notes that the body absorbs and retains less calcium after menopause. When appetite is reduced on a GLP-1 medication, these foods can be easy to skip, so it is worth checking that they still show up in your week.
Vitamin D helps your body absorb calcium. ODS lists a recommended amount of 15 mcg (600 IU) for adults 19 to 70 and 20 mcg (800 IU) for adults 71 and older. Very few foods contain it naturally; fortified milk, fatty fish such as salmon and trout, and fortified cereals are the main dietary sources. A blood test for 25-hydroxyvitamin D can show whether your level is adequate, and ODS describes 20 ng/mL or above as adequate for most people.
In the 2017 trial, the groups that kept the most lean mass also kept the most hip bone density. Our protein and muscle guide explains how protein intake relates to muscle during weight loss, and the protein calculator gives a starting estimate you can review with your provider.
NIAMS also recommends drinking alcohol only in moderation and not smoking, both of which support bone health.
The US Preventive Services Task Force (USPSTF) updated its recommendation in January 2025. It recommends osteoporosis screening with a DXA bone density scan for women 65 and older, and for postmenopausal women younger than 65 who are found to be at increased risk using a clinical risk assessment. For men, the USPSTF found the evidence insufficient to recommend for or against routine screening and leaves the decision to clinical judgment.
If you are in one of these groups and planning significant weight loss, it is reasonable to ask your clinician whether a baseline scan makes sense. For women in midlife, our article on weight changes around menopause covers how hormonal shifts fit into the picture.
Weight loss in general tends to reduce bone density somewhat, and in one 2024 trial liraglutide alone lowered hip and spine bone density compared with exercise alone. The same trial found that combining the medication with exercise kept bone density stable. Because that trial used an earlier GLP-1 medication, results with semaglutide or tirzepatide may differ.
The evidence is encouraging. In two randomized trials, adding exercise, and especially resistance training, preserved more bone density than weight loss without it or with aerobic exercise alone. Results are averages, so your own response may differ.
ODS notes that many people can meet calcium needs through food, and that supplements are an option when diet falls short. Because needs vary by age, sex, diet and other medications, it is best to review supplements with a licensed provider rather than guessing.
Not everyone does. The USPSTF recommends screening for women 65 and older and for younger postmenopausal women at increased risk. Your clinician can weigh your age, history and planned weight change to decide whether a baseline scan is useful.
If you are starting a GLP-1 program, share any history of fractures, osteoporosis, early menopause, eating disorders or long-term steroid use, and ask how bone health fits into your plan. A licensed provider can help you decide on screening, nutrition and an exercise approach that fits your health. This article is educational and does not determine eligibility for any treatment.
Written by the NewDay Wellness editorial team from the sources above and checked against them before publication, and medically reviewed by Dr. Sean Arora and Dr. Shannon Arora of Arora Health & Aesthetics; see our editorial standards. This article is educational and does not diagnose conditions, establish eligibility for any medication, or replace care from a licensed provider. Compounded medications are not FDA-approved.
The first weeks on a GLP-1 usually mean a low starting dose that your prescriber raises gradually, a quieter appetite, and for many people mild to moderate digestive side effects. Knowing what is common and what to report makes the start easier.
Read articleEvery weight loss method eventually levels off. The physiology behind plateaus, why GLP-1 medications delay them, and how to tell a true plateau from ordinary fluctuation.
Read articleResistance training is the single most effective way to protect muscle and bone while losing weight. Here is what the guidelines recommend, what the research shows, and how to begin safely without a gym background.
Read article